The company also raised its full-year adjusted earnings to a range of $16.10 to $16.60, up from a previous guidance of $13.50 to $14 per share. Eli Lilly said the guidance increase was primarily ...
2 days ago
Insider Monkey via Yahoo
Why Is Eli Lilly and Company (LLY) the Best GLP-1 and Weight Loss Stock to Buy Now?
GuruFocus.com via Yahoo
Decoding Eli Lilly and Co (LLY): A Strategic SWOT Insight
1 day ago
Investopedia
Eli Lilly Stock Keeps Climbing After Drugmaker's Strong Earnings Report
22 hours ago
The Motley Fool via Yahoo
Eli Lilly (LLY) Q2 2024 Earnings Call Transcript
Morningstar Research via Yahoo
Analyst Report: Eli Lilly and Company
Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio for cancer; Mounjaro, Zepbound, Jardiance, Trulicity, Humalog ...
Houston Chronicle
Mounjaro, Zepbound pour money into Eli Lilly, fueling a better-than-expected second quarter
CNBC
If you invested $1,000 in drugmaker Eli Lilly 10 years ago, here's how much money you'd have now
ETF Trends
Defiance Lists Leveraged Eli Lilly ETF | ETF Trends
Eli Lilly's blowout quarter should quiet investor concerns about the stock
View all
American pharmaceutical company
lilly.com
Eli Lilly and Company is an American pharmaceutical company headquartered in Indianapolis, Indiana, with offices in 18 countries. Its products are sold in approximately 125 countries. Wikipedia
More on Yahoo Finance